Central venous catheters in dialysis: The good, the bad and the ugly

Open Urology and Nephrology Journal

Volumn 5, Issue 1, 2012, Pages 12-18

  Haddad, Nabil J ^a   van Cleef, Sheri ^a   Agarwal, Anil K ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Catheter infection; Central venous catheters; CVC advantages; CVC complications; Fibrin sheath; Hemodialysis; Tunneled catheters; Vascular access

Indexed keywords

ANTIBIOTIC AGENT;

ABSCESS; ANTIBIOTIC THERAPY; ARTERIOVENOUS SHUNT; ARTERY DISSECTION; ARTERY THROMBOSIS; ARTICLE; BACTERIAL ARTHRITIS; BACTERIAL ENDOCARDITIS; BLOOD FLOW; BODY MASS; CATHETER COMPLICATION; CATHETER INFECTION; CATHETER REMOVAL; CATHETER THROMBOSIS; CENTRAL VENOUS CATHETER; CENTRAL VENOUS STENOSIS; DIABETES MELLITUS; DIALYSIS; ENDOVASCULAR SURGERY; FIBRIN SHEATH FOMATION; GLOMERULONEPHRITIS; GLOMERULUS FILTRATION RATE; HEALTH CARE COST; HEART ARRHYTHMIA; HEMATOTHORAX; HEMODIALYSIS; HUMAN; HYPERTENSION; KIDNEY FAILURE; KIDNEY GRAFT; KIDNEY POLYCYSTIC DISEASE; KIDNEY SURGERY; MORBIDITY; MORTALITY; OSTEOMYELITIS; PNEUMOTHORAX; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; SPINAL CORD ABSCESS; STENOSIS; SUBCLAVIAN VEIN CATHETER; VASCULAR ACCESS; VASCULAR ACCESS DEVICE; CATHETER ADHERENCE; CATHETER DYSFUNCTION; CENTRAL VENOUS CATHETERIZATION; EQUIPMENT FAILURE; HEART ATRIUM THROMBOSIS; PATIENT SAFETY; VEIN OCCLUSION;

EID: 84861902742     PISSN: None     EISSN: 1874303X     Source Type: Journal    
DOI: 10.2174/1874303X01205010012     Document Type: Article

References (38)

1. K/DOQI clinical practice guidelines for vascular access. Am J Kidney Dis 2006; 48:S248-57.
2. Fistula First [homepage on the Internet]. [cited 2011 Oct 15]. Available from: http://fistulafirst.org/
3. Beathard GA: ASDIN Curriculum. Clinton, Mississippi 2008.
4. Schwab SJ, Beathard G. The hemodialysis catheter conundrum: hate living with them, but can't live without them. Kidney Int 1999; 56: 1-17.
5. Forauer, AR, Glockner JF. Importance of US Findings in Access Planning during Jugular Vein Hemodialysis Catheter Placements. J Vasc Inter Radioo 2000; 11: 233-8.
6. Laméris JS, Post PJ, Zonderland HM, Gerritsen PG, Kappers-Klunne MC, Schütte HE. Percutaneous placement of Hickman catheters: comparison of sonographically guided and blind techniques. Am J Roentgenol 1990; 155: 1097-9.
7. NKF-K/DOQI Clinical Practice Guidelines for Vascular Access: update 2000. Am J Kidney Dis 2001; 37: S137-S181.
8. Vanherweghem JL, Cabolet P, Dhaene M, et al. Complications related to subclavian catheters for hemodialysis. Report and review. Am J Nephrol 1986; 6: 339-45.
9. Hoshal VL Jr, Ause RG, Hoskins PA. Fibrin sleeve formation on indwelling subclavian central venous catheters. Arch Surg 1971; 102: 353-8.
10. Mehall JR, Saltzman DA, Jackson RJ, Smith SD. Fibrin sheath enhances central venous catheter infection. Crit Care Med 2002; 30: 908-12.
11. Vaudaux P, Pittet D, Haeberli A, et al. Fibronectin is more active than fibrin or fibrinogen in promoting Staphylococcus aureus adherence to inserted intravascular catheters. J Infect Dis 1993; 167:633-41.
12. Crowley AL, Peterson GE, Benjamin DK Jr, et al. Venous thrombosis in patients with short- and long-term central venous catheter-associated Staphylococcus aureus bacteremia. Crit Care Med 2008; 36: 385-90.
13. Hannah EL, Stevenson KB, Lowder CA, et al. Outbreak of hemodialysis vascular access site infections related to malfunctioning permanent tunneled catheters: making the case for active infection surveillance. Infect Control Hosp Epidemiol 2002; 23: 538-41.
14. Haire WD, Atkinson JB, Stephens LC, Kotulak GD. Urokinase vs recombinant tissue plasminogen activator in thrombosed central venous catheters: A double-blinded, randomized trial. Thromb Haemost 1994; 72: 543-7.
15. Haire WD, Deicher SR, Mullane KM, et al. Recombinant urokinase for restoration of patency in occluded central venous access devices. A double-blind, placebo-controlled trial. Thromb Haemost 2004; 92:575-82.
16. Saxena AK, Panhotra BR, Al-Mulhim AS. Vascular access related infections in hemodialysis patients. Saudi J Kidney Dis Transpl 2005; 16:46-71.
17. Inrig JK, Reed SD, Szczech LA, et al. Relationship between clinical outcomes and vascular access type among hemodialysis patients with Staphylococcus aureus bacteremia. Clin J Am Soc Nephrol 2006; 1:518-24.
18. Beathard A. Urbanes A. Infection associated with tunneled hemodialysis catheters. Semin Dial 2008; 21:528-38.
19. Fernández-Cean J, Alvarez A, Burguez S, Baldovinos G, Larre-Borges P, Cha M. Infective endocarditis in chronic haemodialysis: two treatment strategies. Nephrol Dial Transplant 2002; 17: 2226-30
20. Beathard GA. Management of bacteremia associated with tunneled hemodialysis catheters. J Am Soc Nephrol 1999; 10:1045-9.
21. Agarwal AK, Patel BM, Haddad NJ. Central vein stenosis: a nephrologist's perspective. Semin Dial 2007; 20: 53-62.
22. Agarwal AK. Central Vein Stenosis: Current Concepts. Adv Chronic Kid Dis 2009; 16: 360-70.
23. Schwab SJ, Quarles LD, Middleton JP, Cohan RH, Saeed M, Dennis VW. Hemodialysis-associated subclavian vein stenosis. Kidney Int 1988; 33: 1156-9.
24. Barrett N, Spencer S, McIvor J, Brown EA. Subclavian stenosis: a major complication of subclavian dialysis catheters. Nephrol Dial Transplant 1988; 3: 423-5.
25. Jassal SV, Pierratos A, Roscoe JM. Venous stenosis and thrombosis associated with the use of internal jugular vein catheters for hemodialysis. ASAIO J 1999; 45: 356-9.
26. Agarwal AK, Patel BM, Farhan NJ. Central venous stenosis in hemodialysis patients is a common complication of ipsilateral central vein catheterization. J Am Soc Nephrol 2004; 15:368-9.
27. Shemesh D, Olsha O, Berelowitz D, Zaghal I, Goldin I, Zigelman C. Intra-operative central vein angioplasty during arteriovenous access creation. J Vasc Access 2005; 6: 187-91.
28. Dhingra RK, Young EW, Hulbert-Shearon TE, Leavey SF, Port FK. Type of vascular access and mortality in U.S. hemodialysis patients. Kidney Int 2001; 60: 1443-51.
29. Brad CA, Joseph AE, Neil RP, Michael JK, Nancy EF, Josef C. Type of Vascular Access and Survival among Incident Hemodialysis Patients: The Choices for Healthy Outcomes in Caring for ESRD (CHOICE) Study. J Am Soc Nephrol 2005; 16: 1449-55.
30. Pisoni, Ronald L, Young EW, et al. J Vascular access use in Europe and the United States: Results from the DOPPS. Kidney Int 2002; 61: 305-16.
31. Eggers PW, Chen S, Ebben JP, Collins AJ. Fistula is the least expensive form of vascular access in terms of total medicare expenditures. J Am Soc Nephrol 2005; 16:259 A.
32. Beathard GA. Strategy for maximizing the use of arteriovenous fistulae. Semin Dial 2000; 13: 291-6.
33. Rayner HC, Pisoni RL, Gillespie BW, et al. Creation, cannulation and survival of arteriovenous fistulae: data from the Dialysis Outcomes and Practice Patterns Study. Kidney Int 2003; 63: 323-30.
34. Pisoni RL, Young EW, Dykstra DM, et al. Vascular access use in Europe and the United States: Results from the DOPPS. Kidney Int 2002; 61: 305-16.
35. USRDS. Annual Data Report 2009. Available at http://www.usrds.org/atlas09.aspx [Accessed: October 2011].
36. Silva MB Jr, Hobson RW 2nd, Pappas PJ, et al. A strategy for increasing use of autogenous hemodialysis access procedures: impact of preoperative noninvasive evaluation. J Vasc Surg 1998; 27: 302-8.
37. Asif A, Unger SW, Briones P, et al. Creation of secondary arteriovenous fistulas: maximizing fistulas in prevalent hemodialysis patients. Full. Semin Dial 2005; 18: 420-4.
38. Asif A, Cherla G, Merrill D, Cipleu CD, Briones P, Pennell P. Conversion of tunneled hemodialysis catheter-consigned patients to arteriovenous fistula. Kidney Int 2005; 67: 2399-406.